CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to develop user-friendly microfluidic systems for point-of-care testing, enhancing immunodiagnostics by utilizing capillary forces for sample handling. This technology seeks to simplify the testing process, allowing non-technical users to perform accurate biological tests with minimal sample volume.
The worldwide in vitro diagnostic (IVD) is continually growing.
At least 36% of the IVD market comprises point-of-care (POC)tests, which are performed by healthcare professional in various settings or by patients themselves. A large number ofcompanies entered the POC testing market in the recent years while bringing significant technological improvements andnovel concepts to this market.
Yet, many important needs for immunodiagnostics are unmet:
POC tests still require relativelylarge volumes of…
KARLSRUHER INSTITUT FUER TECHNOLOGIE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, Rueschlikon
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
